STRO
Sutro Biopharma·NASDAQ
--
--(--)
--
--(--)
STRO fundamentals
Sutro Biopharma (STRO) released its earnings on Aug 7, 2025: revenue was 63.74M (YoY +147.98%), beat estimates; EPS was -1.4 (YoY +76.27%), beat estimates.
Revenue / YoY
63.74M
+147.98%
EPS / YoY
-1.4
+76.27%
Report date
Aug 7, 2025
Earnings Call
4:00 PM on Aug 7, 2025
Meeting link.EPS
Actual | -8.4 | 9.4 | 4.5 | -15.4 | -6.6 | -1.3 | -6.7 | -8.3 | -8.4 | -5.5 | -3.7 | -5.9 | -8.5 | -6.4 | -8.1 | 5.2 | -9.5 | -5.9 | -5.9 | -8.3 | -9.1 | -1.4 | |||||
Forecast | -6.8857 | -6.4375 | -5.0714 | -5.7 | -6.2333 | -4.1396 | -6.5133 | -7.5917 | -7.5741 | -6.4429 | -2.8875 | -6.2125 | -7.8375 | -7.325 | -7.3602 | -2.7127 | -9.2159 | -7.9163 | -7.3459 | -8.3041 | -6.4257 | -3.8241 | |||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -21.99% | +246.02% | +188.73% | -170.18% | -5.88% | +68.60% | -2.87% | -9.33% | -10.90% | +14.63% | -28.14% | +5.03% | -8.45% | +12.63% | -10.05% | +291.69% | -3.08% | +25.47% | +19.68% | +0.05% | -41.62% | +63.39% |
Revenue
Actual | -- | -- | -- | -- | -- | 7.15M | 9.47M | 17.82M | 8.28M | 14.66M | 28.05M | 8.52M | 10.45M | 5.90M | 28.10M | 25.15M | 8.62M | 12.67M | 10.41M | 16.92M | 113.73M | 13.01M | 25.71M | 8.52M | 14.80M | 17.40M | 63.74M |
Forecast | -- | -- | -- | -- | -- | 10.70M | 6.96M | 7.29M | 8.27M | 4.80M | 13.29M | 8.97M | 11.81M | 10.46M | 16.01M | 35.71M | 14.52M | 12.13M | 12.56M | 13.01M | 57.36M | 12.07M | 21.02M | 15.29M | 12.15M | 11.61M | 15.84M |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -33.13% | +36.04% | +144.63% | +0.13% | +205.42% | +111.01% | -5.04% | -11.54% | -43.62% | +75.54% | -29.59% | -40.60% | +4.47% | -17.08% | +30.13% | +98.29% | +7.75% | +22.27% | -44.28% | +21.79% | +49.83% | +302.50% |
Earnings Call
You can ask Aime
What does Sutro Biopharma do and what are its main business segments?What guidance did Sutro Biopharma's management provide for the next earnings period?What factors drove the changes in Sutro Biopharma's revenue and profit?What is the market's earnings forecast for Sutro Biopharma next quarter?What is Sutro Biopharma's gross profit margin?What is the revenue and EPS growth rate for Sutro Biopharma year over year?Did Sutro Biopharma beat or miss consensus estimates last quarter?What were the key takeaways from Sutro Biopharma's earnings call?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
